SELECT MEDICAL HOLDINGS CORP (SEM) Stock Analyst Earnings Estimates
NYSE:SEM - New York Stock Exchange, Inc. - US81619Q1058 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.205B 12.16% | 6.334B 2.08% | 6.664B 5.22% | 6.549B -1.73% | 5.829B -10.99% | 6.475B 11.08% | |
| EBITDA YoY % growth | 916.419M 34.12% | 609.108M -33.53% | 763.616M 25.37% | 783.91M 2.66% | 632.47M -19.32% | 746.95M 18.10% | |
| EBIT YoY % growth | 713.774M 49.45% | 403.283M -43.50% | 554.874M 37.59% | 617.71M 11.32% | 440.79M -28.64% | 510.14M 15.73% | |
| Operating Margin | 11.50% | 6.37% | 8.33% | 9.43% | 7.56% | 7.88% | |
| EPS YoY % growth | 2.98 58.51% | 1.23 -58.72% | 1.99 61.79% | 2.05 3.03% | 1.63 -20.30% | 2.24 37.00% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.29 -19.76% | 0.66 -11.66% | 0.62 3.36% | 0.56 31.07% | 0.44 53.85% | 0.56 -16.16% | 0.67 7.49% | 0.51 -10.39% | 0.49 11.36% |
| Revenue Q2Q % growth | 1.76B 6.10% | 1.881B 5.15% | 1.86B 5.70% | 1.854B 5.27% | 1.842B 4.66% | 1.994B 6.01% | 1.98B 6.45% | 1.966B 6.04% | 1.967B 6.79% |
| EBITDA Q2Q % growth | 185.59M -42.54% | 256.45M 3.39% | 251.51M -45.30% | 230.3M -23.05% | 213.37M 14.97% | 256.22M -0.09% | 277.13M 10.19% | 246.67M 7.11% | 241.98M 13.41% |
| EBIT Q2Q % growth | 128.49M 12.46% | 182.73M -5.79% | 172.55M -50.95% | 150.6M 6.71% | 135.07M 5.12% | 194.39M 6.38% | 215.76M 25.04% | 185.74M 23.33% | 180.98M 33.99% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.43 -6.52% | 0.44 | -0.01 | -1.75% |
| Q2 2024 Q2Q % growth | 0.60 -1.64% | 0.61 | -0.01 | -2.08% |
| Q1 2024 Q2Q % growth | 0.75 33.93% | 0.58 | 0.17 | 29.14% |
| Q4 2023 Q2Q % growth | 0.36 63.64% | 0.36 | 0.00 | 0.40% |
| Q3 2023 Q2Q % growth | 0.46 119.05% | 0.41 | 0.05 | 11.77% |
| Q2 2023 Q2Q % growth | 0.61 41.86% | 0.48 | 0.13 | 26.14% |
| Q1 2023 Q2Q % growth | 0.56 51.35% | 0.44 | 0.12 | 26.82% |
| Q4 2022 Q2Q % growth | 0.22 -40.54% | 0.36 | -0.14 | -39.39% |
| Q3 2022 Q2Q % growth | 0.21 -63.16% | 0.46 | -0.25 | -54.20% |
| Q2 2022 Q2Q % growth | 0.43 -64.75% | 0.56 | -0.13 | -22.98% |
| Q1 2022 Q2Q % growth | 0.37 -54.88% | 0.28 | 0.09 | 33.02% |
| Q4 2021 Q2Q % growth | 0.37 -35.09% | 0.31 | 0.06 | 19.87% |
| Q3 2021 Q2Q % growth | 0.57 1.79% | 0.53 | 0.04 | 7.83% |
| Q2 2021 Q2Q % growth | 1.22 221.05% | 0.56 | 0.66 | 116.16% |
| Q1 2021 Q2Q % growth | 0.82 121.62% | 0.61 | 0.21 | 34.02% |
| Q4 2020 Q2Q % growth | 0.57 83.87% | 0.31 | 0.26 | 83.83% |
| Q3 2020 Q2Q % growth | 0.56 69.70% | 0.29 | 0.27 | 90.14% |
| Q2 2020 Q2Q % growth | 0.38 15.15% | 0.02 | 0.36 | 2,087.43% |
| Q1 2020 Q2Q % growth | 0.37 37.04% | 0.32 | 0.05 | 15.93% |
| Q4 2019 Q2Q % growth | 0.31 | 0.19 | 0.12 | 63.64% |
| Q3 2019 Q2Q % growth | 0.33 | 0.21 | 0.12 | 57.65% |
| Q2 2019 Q2Q % growth | 0.33 | 0.33 | 0.00 | -0.99% |
| Q1 2019 Q2Q % growth | 0.27 | 0.28 | -0.01 | -2.49% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.761B 5.73% | 1.754B | 7.22M | 0.41% |
| Q2 2024 Q2Q % growth | 1.76B 5.08% | 1.762B | -2.337M | -0.13% |
| Q1 2024 Q2Q % growth | 1.789B 7.44% | 1.756B | 32.809M | 1.87% |
| Q4 2023 Q2Q % growth | 1.659B 4.89% | 1.656B | 2.856M | 0.17% |
| Q3 2023 Q2Q % growth | 1.666B 6.24% | 1.643B | 22.694M | 1.38% |
| Q2 2023 Q2Q % growth | 1.675B -47.41% | 1.659B | 15.528M | 0.94% |
| Q1 2023 Q2Q % growth | 1.665B 4.09% | 1.662B | 2.98M | 0.18% |
| Q4 2022 Q2Q % growth | 1.581B 1.39% | 1.6B | -18.544M | -1.16% |
| Q3 2022 Q2Q % growth | 1.568B 2.19% | 1.575B | -7.206M | -0.46% |
| Q2 2022 Q2Q % growth | 3.184B 2.37% | 1.598B | 1.586B | 99.27% |
| Q1 2022 Q2Q % growth | 1.6B 3.43% | 1.577B | 22.547M | 1.43% |
| Q4 2021 Q2Q % growth | 1.56B 6.80% | 1.537B | 22.811M | 1.48% |
| Q3 2021 Q2Q % growth | 1.534B 7.75% | 1.458B | 76.221M | 5.23% |
| Q2 2021 Q2Q % growth | 3.11B 152.33% | 1.451B | 1.659B | 114.37% |
| Q1 2021 Q2Q % growth | 1.547B 9.32% | 1.457B | 89.5M | 6.14% |
| Q4 2020 Q2Q % growth | 1.461B 6.25% | 1.425B | 35.5M | 2.49% |
| Q3 2020 Q2Q % growth | 1.424B 2.20% | 1.38B | 43.9M | 3.18% |
| Q2 2020 Q2Q % growth | 1.233B -9.45% | 1.166B | 66.7M | 5.72% |
| Q1 2020 Q2Q % growth | 1.415B 6.79% | 1.381B | 33.6M | 2.43% |
| Q4 2019 Q2Q % growth | 1.375B | 1.349B | 25.6M | 1.90% |
| Q3 2019 Q2Q % growth | 1.393B | 1.327B | 66.3M | 5.00% |
| Q2 2019 Q2Q % growth | 1.361B | 1.36B | 1.4M | 0.10% |
| Q1 2019 Q2Q % growth | 1.325B | 1.341B | -16.4M | -1.22% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1.38% | 0% | 11.23% |
| Revenue | 0% | 0.63% | -1.43% | -7.71% |